Literature DB >> 31194579

Canadian Tissue Repository Network Biobank Certification Program: Update and Review of the Program from 2011 to 2018.

Victoria Hartman1, Brent Gali1,2, Simon Dee1,2,3, Sheila O'Donoghue1,2,3, Tamsin Tarling1,2, Rebecca Barnes3, Manon de Ladurantaye4, Anne-Marie Mes-Masson4,5, Peter H Watson1,2,3.   

Abstract

The Canadian Tissue Repository Network (CTRNet) Biobank Certification Program was first launched in 2011 to foster translational research through improved access to high quality biospecimens. This was accomplished by creating and providing biobank education and through the establishment and deployment of common standards to harmonize biospecimen quality and approaches to governance. The CTRNet program comprises registration and certification steps as two linked phases. In the two-step registration phase, the biobank is registered into the system, and an individual completes an overview educational module. In the subsequent certification phase, biobanks undergo a seven-step process, including inviting team members, assigning and completing relevant education modules, uploading documents, and undergoing a documentation audit. As of June 2018, there were 251 biobanks engaged in the CTRNet program, 193 had completed registration, and 40 were fully certified. Over 3/4 of these biobanks completed registration within a week and over 1/3 completed certification within a month. Among registered biobanks, 163 were associated with North American institutions, while 30 were from other international locations, including Australia, Europe, and Asia. The CTRNet program enables biobanks to adopt standards with a flexible approach to accommodate different types of biobanks and a measured investment of effort, creating the foundation for increased access to high quality biospecimens.

Keywords:  certification; education; quality; standards

Mesh:

Year:  2019        PMID: 31194579     DOI: 10.1089/bio.2019.0015

Source DB:  PubMed          Journal:  Biopreserv Biobank        ISSN: 1947-5543            Impact factor:   2.300


  1 in total

1.  Biobanking in the COVID-19 Era and Beyond: Part 2. A Set of Tool Implementation Case Studies.

Authors:  Clare M Allocca; Emma Snapes; Monique Albert; Marianna J Bledsoe; Marta G Castelhano; Mieke De Wilde; Koh Furuta; Zisis Kozlakidis; Dunja Martin; Anabela Martins; Shannon J McCall; Brent Schacter
Journal:  Biopreserv Biobank       Date:  2020-11-18       Impact factor: 2.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.